Aequitas Research puts out a weekly update on the deals that have been covered by the team recently along with updates for upcoming IPOs.
Asia ECM pipeline continued to build up this week. Grab announced the details of its SPAC listing with a target market value of about US$40bn. The company will raise more than US$4bn proceeds from a fully committed PIPE which include BlackRock, MSIM, T. Rowe Price, Fidelity, Janus Henderson, Mubadala, Nuveen, Permodalan Nasional Berhad and Temasek. We shared our initial thoughts in:
In Hong Kong, it was reported that ByteDance has kicked off IPO preparations for some of its main businesses, which includes Douyin. The company was still deliberating on the listing venue but it is likely that it will conduct a separate listing of its overseas assets.
Dida re-filed with HKEX after its initial application from October last year lapsed last week. The company is probably trying to get ahead of Didi Chuxing’s listing as the latter filed confidentially for a US listing last week. There were also news reports of SF REIT looking to pre-market this month and JD Logistics will be seeing listing approval at the end of this month.
Trip.com’s secondary listing in Hong Kong will debut on Monday and the company’s ADR corrected in line with our earlier expectation but the spread out allocation might weigh on near-term performance.
Our upcoming IPO coverage this week centered around Healthcare names. Zhaoke Ophthalmology Pharma (6622 HK) launched its bookbuild on Friday and it is expected to price this coming Wednesday.
We also looked at We Doctor, Bio-Thera, Medlive, and Edding Group. :
WeDoctor (微医) Pre-IPO - A More Focused Online Medical Svc Provider than Ping An Good Doctor
WeDoctor (微医) Pre-IPO -App Walk Through - The Online Medical Directory and More
We Doctor (微医) Pre-IPO - Peer Comparison - Picking Its Battles Wisely
Medlive (医脉通) Pre-IPO: Internet Hospital a Different Ball Game
Bio-Thera Solutions (百奥泰) A+H: Recent Termination of Drug Candidates
Edding Group (亿腾医药) Pre-IPO: Distributor Turning Pharmaceutical
Edding Group (亿腾医药) Pre-IPO: Notes from Latest Financials and Its Related Party
In the US, Waterdrop Inc prospectus is publicly filed with the SEC. The online insurance technology company is looking to raise about US$500m but there had been news reports that the company was facing pushback from local regulators.
Aside from Didi Chuxing, Ximalaya FM also filed confidentially for up to US$1bn IPO. Soulgate, a Chinese social networking app operator, and Keep, a Chinese fitness app are looking to file their prospectuses this month.
This week we took a brief look at TuSimple, a pre-commercialization autonomous technology vendor for truck freights, before it debuted on Thursday.
In Thailand, Ngern Tid Lor (NTL TB), launched its US$1bn bookbuild. Books will close on 27th April.
Ngern Tid Lor Pre-IPO - Pre-COVID growth track record has been very strong
Ngern Tid Lor Pre-IPO - Peer Comparison - Playing Catch up After Being Left Behind
Ngern Tid Lor IPO - Not Really at a Large Discount but the Overall Sector Has Been Doing Very Well
In the Philippines, we followed-up with a peer comparison of Monde Nissin against competitors.
Singapore ECM suffered a setback this week. ThaiBev announced on Friday that they have decided to defer the Proposed Spin-off listing of BeerCo citing uncertain market conditions and volatile outlook. We had discussed management’s valuation expectation of BeerCo vs. the likely valuation it can command in our earlier note. Core REIT has also shelved its IPO citing weak demand and volatile market conditions.
ThaiBev BeerCo Pre-IPO - Valuation Updates and Crystallizing Growth Potential for BeerCo
Placements were spread out over the past week, with Regis Resources (RRL AU) in Australia and Lasalle Logiport Reit (3466 JP) in Japan. Kakao Corp (035720 KS)’s founder sold about US$450m worth of shares.
Regis Resources Placement - A Big, Pricey Quality Purchase but Not Set in Stone
LaSalle Logiport REIT Placement - Well-Flagged Property with Upside Potential
Credits to Clarence Chu for helping out with the Weekly Update.
Our overall accuracy rate is 73.9% for IPOs and 67.2% for Placements
(Performance measurement criteria is explained at the end of the note)
Hong Kong/China
U.S.
India
Others
Join 55,000+ investors, including top global asset managers overseeing $13+ trillion.
Upgrade later to our paid plans for full-access.